Clinical and radiographic evaluation bone healing by grafting of polymer of Injectable Platelet Rich Fibrin (i-PRF) and hydroxyapatite in jaw bony defects: A double blinded randomised control trial.

Clinicoradiographic evaluation of polymer of Injectable Platelet Rich Fibrin (i-PRF) and hydroxyapatite as bone graft substitute in maxillomandibular bony defects: A double blinded randomised control trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049568

Enrollment

Registered

2023-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: HA plus iPRF: polymer of hydroxyapatite and injectable plasma rich fibrin as bone graft substitute in post enucleation bone defect Control Intervention1: HA: hydroxyapatite bone graft s

Eligibility

Inclusion criteria

Inclusion criteria: Maxillomandibular cysts/tumors of 2-6 cm in greatest diameter requiring surgical enucleation.

Exclusion criteria

Exclusion criteria: General contraindications for surgery General contraindications for graft Patients who did not give consent for the procedure

Design outcomes

Primary

Measure	Time frame
faster clinically and radiographically healingTimepoint: clinical at day1, 3 and 7 radiographic at 2 month, 4 month	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactVyakhya Gupta

AIIMS Patna

naqoosh.haidry@gmail.com7096843640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026